Hepatocellular Carcinoma Cases with Five-Year Survival and Prognostic Factors Affecting the Survival Time.

• 資料種別: 記事
• タイトル: Hepatocellular Carcinoma Cases with Five-Year Survival and Prognostic Factors Affecting the Survival Time.
• 著者標目: ONODERA HIROYOSHI; UKAI KATSUAKI; MINAMI YUKO
• 出版年月日等: 1995
• 出版年（W3CDTF）: 1995
• タイトル（掲載誌）: The Tohoku Journal of Experimental Medicine
• 巻号年月日等（掲載誌）: 176 4
• 掲載巻: 176
• 掲載号: 4
• 掲載ページ: 203-211
• 掲載年月日（W3CDTF）: 1995
• ISSN（掲載誌）: 00408727; http://id.crossref.org/issn/00408727
• 出版事項（掲載誌）: Tohoku University Medical Press
• 本文の言語コード: en
• 件名標目: hepatocellular carcinoma; long survival; Cox's proportional hazards model
• 対象利用者: 一般
• 標準番号（その他）: COI : 1:STN:280:BymC3Mbgtlc%3D; PMID : 8578579
• DOI: 10.1620/tjem.176.203; https://doi.org/10.1620/tjem.176.203
• オンライン閲覧公開範囲: インターネット公開
• 関連情報（URI）: http://www.jstage.jst.go.jp/article/tjem1920/176/4/176_4_203/_pdf
• 参照: Incidence of Hepatocellular Carcinoma after Interferon Therapy in Patients with Chronic Hepatitis C.; https://cir.nii.ac.jp/crid/1390001204238004096
• 連携機関・データベース: 国立情報学研究所 : CiNii Research; https://cir.nii.ac.jp/
• 提供元機関・データベース: Japan Link Center; https://japanlinkcenter.org/top; Crossref; https://www.crossref.org; PubMed; https://pubmed.ncbi.nlm.nih.gov; CiNii Articles
• NII論文ID: 130003494795

• 要約等: ONODERA, H., UKAI, K. and MINAMI, Y. <i>Hepatocellular Carcinoma Cases</i> <i>with Five-Year Survival and Prognostic Factors Affecting the Survival Time</i>. Tohoku J. Exp. Med., 1995, <b>176</b> (4), 203-211 - Between 1980 and 1994, 178 patients were confirmed to have hepatocellular carcinoma (HCC) in our hospital. The 5-year survival rates in patients with HCC of stage I, II and IVA were 38.1%, 31.8% and 3.9%, respectively. No patient in stage III or IVB survived for more than four years. The 5-year survival rates of the patients treated by hepatic resection, ultrasonically guided percutaneous ethanol injection and transcatheter hepatic arterial embolization were 53.7%, 38.7% and 13.5%, respectively. The logrank test showed a significant difference in cumulative survival rates obtained in patients with HCC according to the tumor stage (<i>p</i><0.001) or principal treatment procedure (<i>p</i><0.001). Twelve patients survived for more than five years. We employed a Cox's proportional hazards model to estimate the factors significantly affecting the survival time. Variables with statistical significance were the clinical stage (<i>p</i><0.001), tumor size (maximal tumor diameter) (<i>p</i>< 0.001) and patient's age (<i>p</i><0.05). Conclusively, patients in the early stage of HCC associated with mild liver cirrhosis have a significantly better chance for long survival.
• DOI: 10.1620/tjem.176.203
• オンライン閲覧公開範囲: インターネット公開
• 連携機関・データベース: 科学技術振興機構 : J-STAGE; http://www.jstage.jst.go.jp